“OXXEL (Oxaliplatin plus Xeloda) versus OXAFAFU (Oxaliplatin plus folinic acid-modulated 5-fluorouracil i.v. bolus) every 2 weeks in metastatic colorectal carcinoma (MCC): preliminary safety and activity analysis”

Sandomenico C; Filippelli G; Massidda B; Putzu C; Natale D; Palmeri S; Maiorino L; Condemi G; Leo S; Gambardella A Comella P

Risultato della ricerca: Paper

Lingua originaleUndefined/Unknown
Stato di pubblicazionePublished - 2006

Cita questo

“OXXEL (Oxaliplatin plus Xeloda) versus OXAFAFU (Oxaliplatin plus folinic acid-modulated 5-fluorouracil i.v. bolus) every 2 weeks in metastatic colorectal carcinoma (MCC): preliminary safety and activity analysis”. / Sandomenico C; Filippelli G; Massidda B; Putzu C; Natale D; Palmeri S; Maiorino L; Condemi G; Leo S; Gambardella A Comella P.

2006.

Risultato della ricerca: Paper

@conference{84cf932ebd6a463390fefbf3575609f3,
title = "“OXXEL (Oxaliplatin plus Xeloda) versus OXAFAFU (Oxaliplatin plus folinic acid-modulated 5-fluorouracil i.v. bolus) every 2 weeks in metastatic colorectal carcinoma (MCC): preliminary safety and activity analysis”",
author = "{Sandomenico C; Filippelli G; Massidda B; Putzu C; Natale D; Palmeri S; Maiorino L; Condemi G; Leo S; Gambardella A Comella P} and Sergio Palmeri",
year = "2006",
language = "Undefined/Unknown",

}

TY - CONF

T1 - “OXXEL (Oxaliplatin plus Xeloda) versus OXAFAFU (Oxaliplatin plus folinic acid-modulated 5-fluorouracil i.v. bolus) every 2 weeks in metastatic colorectal carcinoma (MCC): preliminary safety and activity analysis”

AU - Sandomenico C; Filippelli G; Massidda B; Putzu C; Natale D; Palmeri S; Maiorino L; Condemi G; Leo S; Gambardella A Comella P

AU - Palmeri, Sergio

PY - 2006

Y1 - 2006

UR - http://hdl.handle.net/10447/12172

M3 - Paper

ER -